Drugs / unfractionated heparin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00064428 | Aug 2003 → Feb 2006 | thrombotic disease | GlaxoSmithKline | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | unfractionated heparin | “unfractionated heparin [UFH] is not indicated” PMID 16537725 ↗ Mar 2006 |
| Known as | UFH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00064428 ↗ |
| Route | Intravenous | “UFH IV bolus” NCT00064428 ↗ |